Novo Nordisk reported results on its next-generation obesity drug in diabetes patients, including data on weight loss that ...
Novo Nordisk stock was down more than 8% Monday morning after the Danish drugmaker shared new data on its next-generation GLP ...
Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...